Jane J. Zara

Array ( [id] => 7103858 [patent_doc_number] => 20050106584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Alu-derived exons and uses thereof for detection and treatment of genetic diseases' [patent_app_type] => utility [patent_app_number] => 10/853641 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 22278 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106584.pdf [firstpage_image] =>[orig_patent_app_number] => 10853641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427525 [patent_doc_number] => 20040265882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Diabetes gene' [patent_app_type] => new [patent_app_number] => 10/845572 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18864 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265882.pdf [firstpage_image] =>[orig_patent_app_number] => 10845572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070193 [patent_doc_number] => 20070191295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Gene silencing by systemic rna interference' [patent_app_type] => utility [patent_app_number] => 10/555904 [patent_app_country] => US [patent_app_date] => 2004-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19461 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191295.pdf [firstpage_image] =>[orig_patent_app_number] => 10555904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 569274 [patent_doc_number] => 07462602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Anti-scarring ribozymes and methods' [patent_app_type] => utility [patent_app_number] => 10/836670 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11069 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462602.pdf [firstpage_image] =>[orig_patent_app_number] => 10836670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6947220 [patent_doc_number] => 20050198708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Plant protein disulfide isomerase' [patent_app_type] => utility [patent_app_number] => 10/818633 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12007 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20050198708.pdf [firstpage_image] =>[orig_patent_app_number] => 10818633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7423039 [patent_doc_number] => 20040265302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Preventing airway mucus production by administration of EGF-R antagonists' [patent_app_type] => new [patent_app_number] => 10/816159 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 33632 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265302.pdf [firstpage_image] =>[orig_patent_app_number] => 10816159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322937 [patent_doc_number] => 20090060927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination' [patent_app_type] => utility [patent_app_number] => 10/811226 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8078 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060927.pdf [firstpage_image] =>[orig_patent_app_number] => 10811226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667609 [patent_doc_number] => 20060172959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Selected rna motifs to include cell death and/or apoptosis' [patent_app_type] => utility [patent_app_number] => 10/550722 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9506 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172959.pdf [firstpage_image] =>[orig_patent_app_number] => 10550722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7462097 [patent_doc_number] => 20040166092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Use of viral vectors and charged molecules for gene therapy' [patent_app_type] => new [patent_app_number] => 10/787598 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10758 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20040166092.pdf [firstpage_image] =>[orig_patent_app_number] => 10787598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674667 [patent_doc_number] => 20040127451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Antisense modulation of dual specific phosphatase 6 expression' [patent_app_type] => new [patent_app_number] => 10/774888 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30266 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127451.pdf [firstpage_image] =>[orig_patent_app_number] => 10774888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7305949 [patent_doc_number] => 20040116366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Antisense modulation of protein phosphatase 2 catalytic subunit beta expression' [patent_app_type] => new [patent_app_number] => 10/467008 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26687 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116366.pdf [firstpage_image] =>[orig_patent_app_number] => 10467008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851776 [patent_doc_number] => 20060234967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Human protooncogene and protein encoded therein' [patent_app_type] => utility [patent_app_number] => 10/543751 [patent_app_country] => US [patent_app_date] => 2004-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4342 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234967.pdf [firstpage_image] =>[orig_patent_app_number] => 10543751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776704 [patent_doc_number] => 20060105344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Modulation of deubiquitinase family members' [patent_app_type] => utility [patent_app_number] => 10/542024 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14667 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105344.pdf [firstpage_image] =>[orig_patent_app_number] => 10542024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608408 [patent_doc_number] => 20060269924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Modulation of telomere-initiated cell signaling' [patent_app_type] => utility [patent_app_number] => 10/553001 [patent_app_country] => US [patent_app_date] => 2004-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 12820 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269924.pdf [firstpage_image] =>[orig_patent_app_number] => 10553001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632267 [patent_doc_number] => 20060148737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Wound healing method and kits' [patent_app_type] => utility [patent_app_number] => 10/540934 [patent_app_country] => US [patent_app_date] => 2003-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6541 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148737.pdf [firstpage_image] =>[orig_patent_app_number] => 10540934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473915 [patent_doc_number] => 20040121977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Antisense modulation of activating transcription factor 3 expression' [patent_app_type] => new [patent_app_number] => 10/744831 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25772 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121977.pdf [firstpage_image] =>[orig_patent_app_number] => 10744831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776341 [patent_doc_number] => 20060104981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Prophylactic/therapeutic agent for cancer' [patent_app_type] => utility [patent_app_number] => 10/539630 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28630 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104981.pdf [firstpage_image] =>[orig_patent_app_number] => 10539630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264983 [patent_doc_number] => 20040242519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Antisense oligonucleotides for treatment of proliferating cells' [patent_app_type] => new [patent_app_number] => 10/739946 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 2826 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242519.pdf [firstpage_image] =>[orig_patent_app_number] => 10739946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4478398 [patent_doc_number] => 07906641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof' [patent_app_type] => utility [patent_app_number] => 10/539446 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2773 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906641.pdf [firstpage_image] =>[orig_patent_app_number] => 10539446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7296331 [patent_doc_number] => 20040214324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases' [patent_app_type] => new [patent_app_number] => 10/731550 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14706 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214324.pdf [firstpage_image] =>[orig_patent_app_number] => 10731550 [rel_patent_id] =>[rel_patent_doc_number] =>)